We describe the embryonic expression of musculin, a new murine member of the bHLH family of transcription factors. Musculin protein is closely related to human ABF-1, which is expressed in activated B cells, and to epicardin/capsulin/Pod-1, which is expressed in branchial myoblasts, visceral and urogenital mesoderm and epicardium. In situ hybridisation revealed musculin expression in embryos was largely restricted to the embryonic skeletal muscle lineage. While all skeletal muscles expressed the gene, only a subset of myocytes within each muscle were positive, indicating molecular heterogeneity within fetal muscle.
Members of the basic helix-loop-helix (bHLH) family of transcription factors are involved in cell fate determination and tissue differentiation in a number of developmental processes including haemopoiesis, myogenesis and neurogenesis (Jan and Jan, 1993; Murre et al., 1994) . In order to identify novel bHLH genes, we searched genetic databases with a consensus bHLH search motif (Robb et al., 1998b) . Human and murine cDNAs encoding two new bHLH genes were obtained. One of these, epicardin/capsulin/Pod-1 has been described (Hidai et al., 1998; Lu et al., 1998; Quaggin et al., 1998; Robb et al., 1998b) . Here we present the second novel bHLH gene called musculin, based on its prominent expression in embryonic skeletal muscle.
A human EST (YX52E05.R1) with the potential to encode a novel bHLH protein was identified and used to screen human cDNA libraries. A cDNA almost identical in sequence to the recently reported human gene ABF-1 (Massari et al., 1998) was characterised, then used to screen for murine cDNAs. The murine musculin cDNA encoded a 203 amino acid protein with 86% amino acid identity with ABF-1 (Fig. 1A) . The published ABF-1 amino acid sequence diverged from musculin at its C-terminus (see Massari et al., 1998) , although the conceptual translation of our human cDNA showed complete alignment (Fig. 1) . Musculin showed 62% overall identity with epicardin, and differed by only a single amino acid within the bHLH region. The bHLH region was also highly similar to that of bHLH54F, a Drosophila protein expressed in a subset of visceral muscles (outer longitudinal layer) and somatic muscle founder cells (Georgias et al., 1997) .
Northern analysis of polyA + mRNA extracted from a range of adult murine tissues, including lymphoid organs and skeletal muscle, failed to detect musculin expression, although a single transcript of 1.8 kb was observed in RNA from 14.5 days post coitum (dpc) embryos (not shown). However, RNase protection analysis detected low expression in spleen and a range of other adult tissues (Fig. 1C ), including muscle (not shown). Analysis of polyA + RNA from 42 cell lines representing numerous haemopoietic lineages, as well as activated murine splenic B-cells, failed to detect musculin expression. This pattern apparently dif-fers from that of human ABF-1, which is highly expressed in SAC-activated B-cells and adult lymphoid tissues (Massari et al., 1998) .
Musculin expression in 7.5-11.5 dpc embryos was analysed by whole mount in situ hybridisation. Transcripts were first detected at 9.5 dpc in cells within the first and (Massari et al., 1998) and sequences derived from the ABF-1 cDNA clones characterised in this study. Analysis of our cDNA clones suggest a single nucleotide error and reading frame change in the C-terminal region of the published sequence (Massari et al., 1998) . (B) Comparison of the predicted musculin bHLH amino acid sequence with that of selected bHLH factors. Amino acid identities are shown as white on black. The myogenic recognition dipeptide is shaded. References for the protein sequences are as follows: Davis et al., 1987; Edmondson and Olson, 1989; Wolf et al., 1991; Begley et al., 1992; Akazawa et al., 1995; Burgess et al., 1995; Cserjesi et al., 1995; Srivastava et al., 1995; Georgias et al., 1997; Robb et al., 1998b) . (C) RNase protection analysis of adult murine tissues with a musculin riboprobe (nt 306-524). Probe, full-length probe; tRNA control protection in the presence of tRNA; ES cells, embryonic stem cells. Human ABF-1 and murine musculin cDNA sequences can be found at GenBank locations AF087036 and AF087035, respectively. second branchial arches ( Fig. 2A,B) . The central location of these cells within the arches suggested that they might represent mesenchymal precursors of the branchial myogenic plates (Fig. 2D) (Trainor et al., 1994; Lints et al., 1996) . At 10.5 dpc, expression was also observed in the myotomal compartment of rostral somites (Fig. 2B) , and by 11.5 dpc in myotomes along the whole anterio-posterior axis, as well as in cells within the developing forelimbs and hindlimbs (Fig. 2C) . The location of the musculin expressing cells within the limbs was similar (although perhaps not identical) to that observed with myf5 or MyoD riboprobes (Tajbakhsh et al., 1997) . Within the myotome, expression was strongest in the epaxial dermamyotomal lip (Fig. 2G) . Two additional sites of musculin expression were observed. At 9.5 dpc epicardin expression was seen in a region of splanchnic mesoderm located close to the foregut/midgut junction ( Fig. 2A,E) . This expression was transient and no longer detected by 10 dpc. At 10.5 dpc, bilateral, longitudinally oriented bands of musculin-positive cells were seen rostral to the developing forelimb (Fig. 2B) . In transverse sections, it was evident that expression was in a small rod of mesenchymal cells lying ventro-lateral to the ventral tip of dermatomyotome (Fig. 2F) . Although unidentified, these rods, which were adjacent to nerve tissue, may be precursors of diaphragmatic muscles. Again, expression was transient, having disappeared by 11 dpc.
In situ hybridisation to sections of 12.5, 14.5 and 18.5 dpc embryos using 33 P-radiolabelled musculin riboprobes revealed that expression was confined to the skeletal muscle lineage (Fig. 2H-K) . All skeletal muscles of the embryo expressed the gene, including those of the head, neck, trunk, limbs, and diaphragm ( Fig. 2H-J) . Cardiac and smooth muscles were negative. RNase protection revealed peak expression in embryonic limbs around 15 dpc, although expression in neonatal limbs was still robust (not shown). Higher power examination of sections revealed that musculin expression was localised to only a subset of muscle fibres from at least as early as 12.5 dpc (Fig. 2I) .
Although expressed in embryonic skeletal muscle, musculin does not contain the alanine/threonine dipeptide which is found in the basic region of MyoD-related bHLH factors (Fig. 1B) and which plays a critical role in skeletal myogenesis through direct interaction with the MADS box factor Mef2 (Molkentin et al., 1995) . The myotome, from which most skeletal muscles derive, is a complex structure that appears to be assembled from different cell populations arising within the dermomyotome (Tajbakhsh and Sporle, 1998) . Since musculin expression is restricted both within the myotome and within individual muscles, its further characterisation may shed light on this developmental process.
Methods
The genetic sequence database of The National Center for Biotechnology Information (GenBank) was searched with a bHLH search motif as described (Robb et al., 1998b) . The EST YX52E05.R1 was used as a probe to screen a human placental cDNA library, with additional clones obtained from human bone marrow, peripheral blood and HL60 libraries. Murine musculin cDNA clones were obtained from a 11 dpc embryo cDNA library.
Northern blot analysis and RNase protection analysis of polyA + RNA from murine tissues and cell lines were performed as described (Robb et al., 1996; Robb et al., 1998a) . Activated B-cells were prepared by incubation of splenocytes at 5 × 10 5 /ml with 20 mg/ml Escherichia coli LPS (Difco) for 3 days followed by anti-Thy1 T-cell depletion. Protocols for in situ hybridisation of embryos and paraffinembedded sections were as described (Wilkinson, 1992; Lyons et al., 1995) , except that embryos and sections were treated with 20 mg/ml of proteinase K (Boehringer).
